Indications
For temporary relief of flu symptoms.
Pleo Ut S
FDA Label NDC 60681-5402
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Ut S (NDC 60681-5402). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding indications, ingredients, dosage, warning, tamper evident, principal display panel - 5 capsules carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Ingredients
1 capsule contains 330 mg Mycobacterium phlei 4X in a base of lactose.
Dosage
1–2 capsules weekly, either before breakfast or at bedtime.
Warning
If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before taking this product.
Tamper Evident
Do not use this product if imprinted inner blister pack is missing or broken.
Principal Display Panel - 5 Capsules Carton
Pleo™ Ut "S"
CAPSULES 4X
Homeopathic
Decongestant / Broncho-
dilator Medicine
Indications: For temporary
relief of flu symptoms.
5 CAPSULES
Principal Display Panel (5 Capsules Carton)
* Please review the disclaimer below.
